• Domande frequenti
  • Glossario
Chiudi

Domande frequenti

Why are animal models used when testing the safety of a new therapy?
What role do preclinical and clinical trials play in ensuring patient safety?
Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

Vedi tutte le FAQ

Chiudi

Glossario

Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising 
Antibody
Antigen
Base editors

Vedi il Glossario completo

Torna all'indice del glossario

Accelerated assessment

Procedure to reduce the time of assessment of the marketing authorisation application (from 210 to 150 days) for medicines targeting an unmet medical need.

Read related content in the entries on commercialisation of the research pathways.

Torna in alto
Hai trovato le informazioni in questa pagina utili? In caso contrario puoi lasciarci un messaggio per aiutarci a migliorare Mandaci i tuoi commenti